Marché mondial du diagnostic du cancer de la prostate – Tendances et prévisions de l’industrie jusqu’en 2031

Personnalisez votre rapport Personnalisez votre rapport Acheter maintenantAcheter maintenant Exemple de rapport gratuitExemple de rapport gratuit
Maison Medical Devices Global Prostate Cancer Diagnostics Market
Demande de table des matières Demande de table des matières Parler à un analysteParler à un analyste Acheter maintenantAcheter maintenant Renseignez-vous avant d'acheterRenseignez-vous avant Exemple de rapport gratuitExemple de rapport gratuit

Marché mondial du diagnostic du cancer de la prostate – Tendances et prévisions de l’industrie jusqu’en 2031

  • Medical Devices
  • Upcoming Reports
  • Feb 2024
  • Global
  • 350 Pages
  • Nombre de tableaux : 220
  • Nombre de figures : 60
Buy Now Acheter maintenant

Global Prostate Cancer Diagnostics Market

Taille du marché en milliards USD

TCAC :  % Diagram

Diagram Période de prévision
 2024 –2031
Diagram Taille du marché (année de référence)
 USD 4,196.09 Million
Diagram Taille du marché (année de prévision)
 USD 9,327.01 Million
Diagram TCAC
 %
DiagramPrincipaux acteurs du marché
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5 < /li>
Demande de déverrouillage

>Marché mondial du diagnostic du cancer de la prostate, par type de produit (instruments, réactifs et consommables, accessoires), type de diagnostic (tests de dépistage préliminaires, tests de confirmation), groupe d'âge (adulte, pédiatrie, gériatrie), type (adénocarcinome prostatique, carcinome à petites cellules, autres), stade (cancer de la prostate localisé, cancer de la prostate récurrent/avancé, cancer de la prostate résistant à la castration (métastatique, non métastatique), type d'échantillon (sang, tissu, urine, autres), utilisateurs finaux (laboratoires de diagnostic indépendants, hôpitaux, instituts de recherche sur le cancer, cliniques, centres de chirurgie ambulatoire, autres), canal de distribution (appel d'offres direct, vente au détail) - Tendances et prévisions de l'industrie jusqu'en 2031.

Marché du diagnostic du cancer de la prostate

Analyse et taille du marché du diagnostic du cancer de la prostate   

Le diagnostic du cancer de la prostate joue un rôle important dans la détection précoce et la gestion efficace de la maladie. Il comprend l'utilisation d'instruments, de réactifs et de consommables, ainsi que d'accessoires. Le test PSA est le diagnostic préliminaire le plus courant du cancer de la prostate, qui peut ou non nécessiter des tests de confirmation pour la détection du cancer.

L'utilisation de diagnostics du cancer de la prostate présente plusieurs avantages, notamment en contribuant à la détection précoce du cancer de la prostate à des stades localisés et en aidant ainsi les personnes à parvenir à une gestion efficace de leur santé. L'utilisation de diagnostics du cancer de la prostate gagne en popularité dans le monde entier, en particulier dans les marchés émergents où les normes de soins de santé sont de plus en plus strictes.

Data Bridge Market Research analyse que le marché mondial du diagnostic du cancer de la prostate, qui était de 4 196,09 millions USD en 2023, devrait atteindre 9 327,01 millions USD d'ici 2031 et devrait connaître un TCAC de 10,5 % au cours de la période de prévision. Les « adultes » représentent la plus grande part de marché dans le segment des tranches d'âge du marché en raison de la prévalence plus élevée du cancer chez les hommes adultes. En plus des informations sur les scénarios de marché tels que la valeur marchande, le taux de croissance, la segmentation, la couverture géographique et les principaux acteurs, les rapports de marché organisés par Data Bridge Market Research comprennent également des analyses approfondies d'experts, l'épidémiologie des patients, l'analyse du pipeline, l'analyse des prix et le cadre réglementaire.

Portée et segmentation du marché du diagnostic du cancer de la prostate

Rapport métrique

Détails

Période de prévision

2024 à 2031

Année de base

2023

Années historiques

2022 (personnalisable pour 2016-2021)

Unités quantitatives

Chiffre d'affaires en millions USD, volumes en unités, prix en USD

Segments couverts

Par type de produit (instruments, réactifs et consommables, accessoires), type de diagnostic (tests de dépistage préliminaires, tests de confirmation), groupe d'âge (adulte, pédiatrie, gériatrie), type (adénocarcinome prostatique, carcinome à petites cellules, autres), stade (cancer de la prostate localisé, cancer de la prostate récurrent/avancé, cancer de la prostate résistant à la castration (métastatique, non métastatique), type d'échantillon (sang, tissu, urine, autres), utilisateurs finaux (laboratoires de diagnostic indépendants, hôpitaux, instituts de recherche sur le cancer, cliniques, centres de chirurgie ambulatoire, autres), canal de distribution (appel d'offres direct, vente au détail)

Pays couverts

États-Unis, Canada, Mexique, Allemagne, France, Royaume-Uni, Belgique, Lituanie, Autriche, Irlande, Norvège, Pologne, Italie, Espagne, Russie, Turquie, Pays-Bas, Suisse, reste de l'Europe, Japon, Chine, Corée du Sud, Inde, Australie, Singapour, Thaïlande, Malaisie, Indonésie, Philippines, reste de l'Asie-Pacifique, Brésil, Argentine, reste de l'Amérique du Sud, Afrique du Sud, Arabie saoudite, Émirats arabes unis, Égypte, Israël, reste du Moyen-Orient et de l'Afrique.

Acteurs du marché couverts

F. Hoffmann-La Roche Ltd (Suisse), ACON Laboratories, Inc. (États-Unis), HUMASIS (Corée du Sud), Teco Diagnostics (États-Unis), Hologic Inc. (États-Unis), Accuquik Test Kits (États-Unis), MDxHealthcare (Belgique), Abbott (États-Unis), Siemens Healthcare GmbH (Allemagne), OPKO Health Inc. (États-Unis), Myriad Genetics, Inc. (États-Unis), DiaSorin SpA (Italie), Beckman Coulter, Inc. (une filiale de Danaher) (États-Unis), Genomic Health, Inc. (une filiale d'Exact Sciences Corporation) (États-Unis), bioMérieux SA (France), Metamark Genetics, Inc. (États-Unis), Prostatype Genomics (Suisse), Fujirebio (Belgique), Proteomedix (Suisse), Eurolyser Diagnostica GmbH (Autriche)

Opportunités de marché
  • Progrès dans la recherche sur les biomarqueurs
  • Focus sur la médecine personnalisée

Définition du marché

Le diagnostic du cancer de la prostate implique une combinaison d'évaluation des antécédents médicaux, d'examen physique et de tests diagnostiques spécifiques. Les étapes initiales comprennent souvent un toucher rectal (TR) pour évaluer la prostate à la recherche d'anomalies. Des analyses sanguines, telles que le test de l'antigène prostatique spécifique (PSA), mesurent des niveaux élevés d'une protéine associée aux affections de la prostate, y compris le cancer. Des études d'imagerie telles que l'échographie, l'imagerie par résonance magnétique (IRM) ou la tomodensitométrie (TDM) peuvent être utilisées pour visualiser la prostate et les tissus environnants à la recherche de signes de cancer. Une biopsie, généralement guidée par l'imagerie, consiste à prélever des échantillons de tissu de la prostate pour une analyse en laboratoire afin de confirmer la présence de cellules cancéreuses et de déterminer l'agressivité du cancer. Les résultats combinés de ces évaluations aident les médecins à formuler un diagnostic précis et à déterminer un traitement approprié pour le patient.

Dynamique du marché mondial du diagnostic du cancer de la prostate

Conducteurs

  • Vieillissement de la population

The demographic shift towards an aging population is a significant driver for the prostate cancer diagnostics market. Prostate cancer predominantly affects older men, and as the proportion of elderly individuals rises globally, there is a natural increase in the number of people at risk for prostate cancer. The elderly demographic often undergoes routine screenings and diagnostic tests, contributing to the overall demand for prostate cancer diagnostics.

  • Rising Incidence of Prostate Cancer

The incidence of prostate cancer has been steadily increasing, making it a major driver for diagnostic market growth. Factors such as lifestyle changes, environmental influences, and genetic predispositions contribute to the higher occurrence of prostate cancer cases. The heightened awareness of the disease and the importance of early detection have led to more individuals seeking diagnostic evaluations, further fuelling the demand for advanced and accurate diagnostic tools in the market.

Opportunities

  • Advancements in Biomarker Research

Ongoing exploration of new biomarkers associated with prostate cancer, such as genetic mutations, circulating tumor cells, and specific proteins, creates opportunities for the development of highly sensitive and specific diagnostic tests. As researchers uncover more nuanced details about the molecular signatures of prostate cancer, diagnostic companies can leverage this knowledge to enhance the precision and reliability of diagnostic tools, ultimately improving early detection rates and patient outcomes.

  • Focus on Personalized Medicine

The increasing emphasis on personalized medicine in prostate cancer diagnostics presents an opportunity to tailor diagnostic approaches based on individual patient characteristics. Integrating genetic profiling, molecular analysis, and patient-specific factors allows for a more targeted and effective diagnostic strategy. This personalized approach not only enhances the accuracy of prostate cancer diagnosis but also opens avenues for the development of customized treatment plans, aligning with the broader trend in healthcare towards more individualized and patient-centered care.

Restraints/Challenges

  • Limited Specificity of Biomarkers

The challenge lies in the fact that some biomarkers used in prostate cancer diagnostics may lack the specificity needed to accurately distinguish between benign conditions and aggressive forms of the disease. This limitation can result in false-positive results, leading to unnecessary invasive procedures and overtreatment. Improving the specificity of biomarkers is crucial for enhancing the precision of diagnostic tests and ensuring more informed clinical decision-making.

  • Invasive Nature of Diagnostic Procedures

Invasive diagnostic procedures, particularly prostate biopsies, pose a significant challenge due to associated discomfort, potential side effects, and the risk of infection. Patient apprehension and reluctance to undergo these procedures can result in delayed or avoided diagnostic evaluations, potentially leading to missed opportunities for early cancer detection. Developing less invasive or non-invasive diagnostic alternatives is essential to encourage broader patient participation and improve the overall patient experience in prostate cancer diagnostics.

This prostate cancer diagnostics market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the prostate cancer diagnostics Market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

  • In October, 2020 Siemens Healthcare GmbH announced that they have launched Biograph Vision Quadra Extended Axial FoV PET/CT Scanner. This scanner is the industry’s most sensitive extended field view scanner designed for clinical and research purposes. The product is of high clinical use and will increase the demand for cancer diagnostic procedure and will increase the revenue for the company
  • In March, 2020 DiaSorin S.p.A and TTP plc, a leading independent technology and product development company announced that they have signed an exclusive licensing and technology transfer agreement under which DiaSorin will gain access to TTP’s Puckdx TM, a flexible and low-cost platform for the automation of sample-to-answer diagnostic assays. This will increase the advancement in diagnostic business profile for the company and will help in future business development

Global Prostate Cancer Diagnostics Market Scope

The prostate cancer diagnostics market is segmented on the basis of product type, diagnostics type, age group, type, stage, sample type, end user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product Type

  • Instruments
  • Reagents & Consumables
  • Accessories

Diagnostics Type

  • Preliminary Screening Tests
  • Confirmatory Tests

Age Group

  • Adult
  • Pediatric
  • Geriatrics

Type

  • Prostatic Adenocarcinoma
  • Small Cell Carcinoma
  • Others

Stage

  • Localized Prostate Cancer
  • Recurrent/Advanced Prostate Cancer
  • Castration-Resistant Prostate Cancer (Metastatic and Non-Metastatic)

Sample Type

  • Blood
  • Tissue
  • Urine
  • Others

End User

  • Independent Diagnostic Laboratories
  • Hospitals
  • Cancer Research Institutes
  • Clinics
  • Ambulatory Surgical Centers
  • Others

Distribution Channel

  • Direct Tender
  • Retail Sales

Global Prostate Cancer Diagnostics Market Regional Analysis/Insights

The prostate cancer diagnostics market is analyzed and market size insights and trends are provided by product type, diagnostics type, age group, type, stage, sample type, end user and distribution channel.  as referenced above.

The countries covered in the market report are U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Netherlands, Russia, Switzerland, Turkey, rest of Europe, Japan, China, Australia, India, South Korea, Singapore, Indonesia, Thailand, Malaysia, Philippines, rest of Asia-Pacific, Brazil, Argentina, rest of South America, Saudi Arabia, South Africa, U.A.E., Israel, Egypt, and rest of Middle East and Africa.

North America is expected to dominate the market and due to higher healthcare expenditure in the region and well equipped healthcare facilities to perform prostate cancer diagnositc tests.

Asia-Pacific is expected to grow with a highest CAGR in the forecast period due to rising prevalence of prostate cancer.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The Prostate cancer diagnostics market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for Prostate cancer diagnostics market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the Prostate cancer diagnostics market. The data is available for historic period 2010-2020.

Competitive Landscape and Global Prostate Cancer Diagnostics Market Share Analysis

Le paysage concurrentiel du marché du diagnostic du cancer de la prostate fournit des détails par concurrent. Les détails inclus sont la présentation de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les investissements dans la recherche et le développement, les nouvelles initiatives du marché, la présence mondiale, les sites et installations de production, les capacités de production, les forces et les faiblesses de l'entreprise, le lancement du produit, la largeur et l'étendue du produit, la domination des applications. Les points de données ci-dessus fournis ne concernent que l'orientation des entreprises liée au marché du diagnostic du cancer de la prostate.

Certains des principaux acteurs opérant sur le marché du diagnostic du cancer de la prostate sont :

  • F. Hoffmann-La Roche SA (Suisse)
  • ACON Laboratories, Inc. (États-Unis)
  • HUMASIS (Corée du Sud)
  • Teco Diagnostics (États-Unis)
  • Hologic Inc. (États-Unis)
  • Kits de test Accuquik (États-Unis)
  • MDxHealthcare (Belgique)
  • Abbott (États-Unis)
  • Siemens Healthcare GmbH (Allemagne)
  • OPKO Health Inc. (États-Unis)
  • Myriad Genetics, Inc. (États-Unis)
  • DiaSorin SpA (Italie)
  • Beckman Coulter, Inc. (une filiale de Danaher) (États-Unis)
  • Genomic Health, Inc. (une filiale d'Exact Sciences Corporation) (États-Unis)
  • bioMérieux SA (France)
  • Metamark Genetics, Inc. (États-Unis)
  • Génomique du Prostatype (Suisse)
  • Fujirebio (Belgique)
  • Proteomedix (Suisse)
  • Eurolyser Diagnostica GmbH (Autriche)

SKU-

Accédez en ligne au rapport sur le premier cloud mondial de veille économique

Sample Image Cliquez sur l'image pour l'agrandir
  • Tableau de bord d'analyse de données interactif
  • Tableau de bord d'analyse d'entreprise pour les opportunités à fort potentiel de croissance
  • Accès d'analyste de recherche pour la personnalisation et les requêtes
  • Analyse de la concurrence avec tableau de bord interactif
  • Dernières actualités, mises à jour et analyse des tendances
  • Exploitez la puissance de l'analyse comparative pour un suivi complet de la concurrence
Demande de démonstration

Table des matières

  1. introduction
    1. OBJECTIVES OF THE STUDY
    2. MARKET DEFINITION
    3. OVERVIEW of GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET
    4. LIMITATIONs
    5. MARKETS COVERED
  2. MARKET SEGMENTATION
    1. MARKETS COVERED
    2. geographical scope
    3. years considered for the study
    4. currency and pricing
    5. DBMR TRIPOD DATA VALIDATION MODEL
    6. MULTIVARIATE MODELLING
    7. product type LIFELINE CURVE
    8. primary interviews with key opinion leaders
    9. DBMR MARKET POSITION GRID
    10. MARKET end users coverage GRID
    11. vendor share analysis
    12. secondary sourcEs
    13. assumptions
  3. EXECUTIVE SUMMARY
  4. Epidemiology
  5. COMPARATIVE ANALYSIS WITH PARENT MARKET
  6. REGULATORY FRAMEWORK: GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET
    1. REGULATORY SCENARIO IN THE U.S.
    2. REGULATORY SCENARIO IN EUROPEAN UNION
    3. REGULATORY SCENARIO IN JAPAN
    4. REGULATORY SCENARIO IN CHINA
  7. market overview
    1. drivers
      1. INCREASING PREVALENCE OF PROSTATE CANCER
      2. INCREASE RESEARCH & DEVELOPMENT IN PROSTATE CANCER DIAGNOSTIC
      3. INCREASE IN GERIATRIC POPULATION
      4. LAUNCH OF NEW PRODUCTS FOR PROSTATE CANCER DIAGNOSTIC
      5. DISEASE CAUSING PROSTATE CANCER
    2. RESTRAINTS
      1. CONTROVERSY RELATED TO PSA TESTING
      2. HIGH COST OF DIAGNOSTICS PROCEDURE
      3. LACK OF SKILLED AND CERTIFIED PROFESSIONALS
    3. OPPORTUNITIES
      1. RISING INVESTMENT AND FUNDING BY EMERGING PLAYERS
      2. REIMBURSEMENT POLICY FOR PROSTATE CANCER DIAGNOSIS
      3. GOVERNMENT INITIATIVES TOWARDS CANCER DIAGNOSTICS
      4. RISING SURVIVAL RATE DUE TO EARLY DIAGNOSIS OF PROSTATE CANCER
    4. Challenges
      1. STRINGENT REGULATORY REQUIREMENT FOR DIAGNOSTIC PRODUCTS
      2. OPERATIONAL BARRIERS FACED IN CONDUCTING DIAGNOSTICS TESTS
      3. INACCURATE DIAGNOSIS RESULTS
  8. IMPACT OF COVID-19 ON GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET
    1. IMPACT ON PRICE
    2. IMPACT ON DEMAND
    3. IMPACT ON SUPPLY CHAIN
    4. STRATEGIC DECISION BY MANUFACTURERS MADE DURING COVID-19 PANDEMIC
    5. KEY INITIATIVES BY MARKET PLAYERS DURING COVID-19
    6. CONCLUSION
  9. global PROSTATE CANCER DIAGNOSTICS MARKET, BY product type
    1. overview
    2. reagents & consumables
    3. instruments
    4. accessories
  10. GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET, BY DIAGNOSTICS TYPE
    1. overview
    2. preliminary screening tests
      1. Prostate-Specific Antigen (PSA) Test
      2. Digital Rectal Exam (DRE) Test
    3. Confirmatory Tests
      1. PCA3 Test
      2. biopsy
      3. imaging tests
        1. ULTRASOUND
        2. MAGNETIC RESONANCE IMAGING (MRI)
          1. MULTIPARAMETRIC MRI
          2. MRI FUSION-GUIDED PROSTATE BIOPSY
        3. CT SCAN
        4. BONE SCAN
        5. PET/CT SCAN
      4. biomarker
        1. RNA BIOMARKERS
        2. DNA BIOMARKERS
        3. PROTEIN BIOMARKERS
  11. Global prostate cancer diagnostics Market, By type
    1. overview
    2. PROSTATIC ADENOCARCINOMA
    3. small cell carcinoma
    4. Others
  12. GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET, BY AGE GROUP
    1. overview
    2. geriatrics
    3. adult
    4. Pediatric
  13. GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET, BY Stage
    1. overview
    2. LOCALIZED PROSTATE CANCER
    3. RECURRENT/ADVANCED PROSTATE CANCER
    4. CASTRATION-RESISTANT PROSTATE CANCER (METASTATIC AND NON-METASTATIC)
  14. GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET, BY sample type
    1. overview
    2. Blood
    3. tissue
    4. urine
    5. others
  15. GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET, BY end users
    1. overview
    2. Independent Diagnostic Laboratories
    3. hospitals
    4. Clinics
    5. Ambulatory Surgical Centers
    6. Cancer Research Institutes
    7. others
  16. GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET, BY Distribution Channel
    1. overview
    2. direct tender
    3. retail sales
  17. GLOBAL Prostate cancer diagnostics maRKET, BY GEOGRAPHY
    1. OVERVIEW
    2. NORTH AMERICA
      1. u.s.
      2. canada
      3. mexico
    3. europe
      1. GERMANY
      2. FRANCE
      3. u.k.
      4. iTALY
      5. SPAIN
      6. RUSSIA
      7. SWITZERLAND
      8. NETHERLANDS
      9. TURKEY
      10. bELGIUM
      11. REST OF EUROPE
    4. Asia - Pacific
      1. CHINA
      2. JAPAN
      3. India
      4. Australia
      5. SOUTH KOREA
      6. SINGAPORE
      7. THAILAND
      8. MALAYSIA
      9. INDONESIA
      10. Philippines
      11. REST OF ASIA - PACIFIC
    5. south AMERICA
      1. BRAZIL
      2. ARGENTINa
      3. rest of south america
    6. Middle east & africa
      1. SOUTH AFRICA
      2. saudi arabia
      3. uAE
      4. iSRAEL
      5. EGYPT
      6. REST OF MIDDLE EAST & AFRICA
  18. Global Prostate cancer diagnostics market: COMPANY landscape
    1. company share analysis: global
    2. company share analysis: north america
    3. company share analysis: europe
    4. company share analysis: Asia-Pacific
  19. SWOT
  20. company profile
    1. F. Hoffmann-La Roche Ltd
      1. COMPANY SNAPSHot
      2. REVENUE ANALYSIS
      3. company share analysis
      4. product Portfoli0
      5. RECENT DEVELOPMENTs
    2. Abbott
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    3. siemens HEALTHCARE gmbh
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    4. OPko HEALTH INC.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    5. Beckman Coulter, Inc. (A Subsidiary of Danaher)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    6. ACCUQUIK TEST KITS
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    7. acon laboratories inc.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    8. Biomerieux sa
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    9. Diasorin s.p.a
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLI0
      4. RECENT DEVELOPMENTS
    10. Eurolyser Diagnostica GmbH
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    11. FUJIREBIO
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLI
      3. RECENT DEVELOPMENTS
    12. GENOMIC HEALTH, INC., (A SUBSIDIARY OF EXACT SCIENCES CORPORATION)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    13. HOLOGIC, INC.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    14. HUMASIS
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    15. MDXHEALTHCARE
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    16. Metamark genetics, inc.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLI0
      3. RECENT DEVELOPMENTS
    17. Myraid genetics, inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    18. Prostatype Genomics
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    19. PROTEOMEDIX
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    20. TECO DIAGNOSTICS
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
  21. questionnaire
  22. related reports

Liste des tableaux

TABLE 1 CATEGORIZATION UNDER THE CLINICAL LABORATORY IMPROVEMENT AMENDMENTS (CLIA '88) OF 1988

TABLE 2 AGE AND PROBABILITY OF DEVELOPING PROSTATE CANCER

TABLE 3 global PROSTATE CANCER DIAGNOSTICS Market, By product type 2019-2028 (USD Million)

TABLE 4 global PROSTATE CANCER DIAGNOSTICS Market, By product type 2019-2028 (UNits)

TABLE 5 global reagents & consumables in PROSTATE CANCER DIAGNOSTICS Market, By Region, 2019-2028 (USD Million)

TABLE 6 globaL instruments in PROSTATE CANCER DIAGNOSTICS Market, By Region, 2019-2028 (USD Million)

TABLE 7 globaL accessories in PROSTATE CANCER DIAGNOSTICS Market, By Region, 2019-2028 (USD Million)

TABLE 8 global PROSTATE CANCER DIAGNOSTICS Market, By DIAGNOSTICS TYPE, 2019-2028 (USD Million)

TABLE 9 global preliminary screening tests in PROSTATE CANCER DIAGNOSTICS Market, By Region, 2019-2028 (USD Million)

TABLE 10 global Confirmatory Testsin PROSTATE CANCER DIAGNOSTICS Market, By Region, 2019-2028 (USD Million)

TABLE 11 Global prostate cancer diagnostics market, By type, 2019-2028 (USD million)

TABLE 12 Global prostatic Adenocarcinomas in prostate cancer diagnostics market, By Type 2019-2028 (USD Million), By Region

TABLE 13 Global small cell carcinoma in prostate cancer diagnostics market, By type, 2019-2028 (USD million)

TABLE 14 Global Others in prostate cancer diagnostics market, By type, 2019-2028 (USD million)

TABLE 15 global PROSTATE CANCER DIAGNOSTICS Market, By age group 2019-2028 (USD Million)

TABLE 16 global geriatrics in PROSTATE CANCER DIAGNOSTICS Market, By region 2019-2028 (USD Million)

TABLE 17 global severe in PROSTATE CANCER DIAGNOSTICS Market, By region, 2019-2028 (USD Million)

TABLE 18 global severe in PROSTATE CANCER DIAGNOSTICS Market, By region, 2019-2028 (USD Million)

TABLE 19 Global Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 20 Global Localized Prostate Cancer in Prostate Cancer Diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 21 Global Recurrent/Advanced Prostate Cancer in Prostate Cancer Diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 22 Global Castration-Resistant Prostate Cancer (Metastatic and Non-Metastatic) in Prostate Cancer Diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 23 Global Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 24 Global Blood in Prostate Cancer Diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 25 Global Tissue in Prostate Cancer Diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 26 Global Urine in Prostate Cancer Diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 27 Global Others in Prostate Cancer Diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 28 Global Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 29 Global Independent Diagnostic Laboratories in Prostate Cancer Diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 30 Global Hospitals in Prostate Cancer Diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 31 Global Clinics in Prostate Cancer Diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 32 Global Ambulatory Surgical Centers in Prostate Cancer Diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 33 Global Cancer Research Institutes in Prostate Cancer Diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 34 Global Others in Prostate Cancer Diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 35 Global Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 36 Global Direct Tender in Prostate Cancer Diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 37 Global Hospitals in Prostate Cancer Diagnostics Market, By Region, 2019-2028 (USD Million)

TABLE 38 GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 39 North America PROSTATE CANCER DIAGNOSTICS MARKET, By country, 2019-2028 (USD Million)

TABLE 40 North America Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 41 North America Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 42 North America Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 43 North America Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 44 North America Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 45 North America Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 46 North America Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 47 North America Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 48 North America Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 49 North America Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 50 North America Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 51 North America Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 52 North America Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 53 North America Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 54 U.S. Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 55 U.S. Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 56 U.S. Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 57 U.S. Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 58 U.S. Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 59 U.S. Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 60 U.S. Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 61 U.S. Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 62 U.S. Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 63 U.S. Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 64 U.S. Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 65 U.S. Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 66 U.S. Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 67 U.S. Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 68 CANADA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 69 CANADA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 70 CANADA Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 71 CANADA Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 72 CANADA Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 73 CANADA Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 74 CANADA Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 75 CANADA Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 76 CANADA Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 77 CANADA Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 78 CANADA Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 79 CANADA Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 80 CANADA Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 81 CANADA Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 82 MEXICO Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 83 MEXICO Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 84 MEXICO Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 85 MEXICO Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 86 MEXICO Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 87 MEXICO Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 88 MEXICO Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 89 MEXICO Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 90 MEXICO Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 91 MEXICO Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 92 MEXICO Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 93 MEXICO Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 94 MEXICO Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 95 MEXICO Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 96 EUROPE PROSTATE CANCER DIAGNOSTICS MARKET, By country, 2019-2028 (USD Million)

TABLE 97 EUROPE Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 98 EUROPE Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 99 EUROPE Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 100 EUROPE Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 101 EUROPE Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 102 EUROPE Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 103 EUROPE Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 104 EUROPE Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 105 EUROPE Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 106 EUROPE Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 107 EUROPE Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 108 EUROPE Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 109 EUROPE Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 110 EUROPE Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 111 GERMANY Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 112 GERMANY Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 113 GERMANY Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 114 GERMANY Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 115 GERMANY Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 116 GERMANY Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 117 GERMANY Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 118 GERMANY Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 119 GERMANY Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 120 GERMANY Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 121 GERMANY Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 122 GERMANY Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 123 GERMANY Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 124 GERMANY Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 125 FRANCE Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 126 FRANCE Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 127 FRANCE Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 128 FRANCE Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 129 FRANCE Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 130 FRANCE Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 131 FRANCE Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 132 FRANCE Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 133 FRANCE Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 134 FRANCE Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 135 FRANCE Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 136 FRANCE Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 137 FRANCE Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 138 FRANCE Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 139 U.K. Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 140 U.K. Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 141 U.K. Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 142 U.K. Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 143 U.K. Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 144 U.K. Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 145 U.K. Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 146 U.K. Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 147 U.K. Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 148 U.K. Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 149 U.K. Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 150 U.K. Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 151 U.K. Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 152 U.K. Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 153 ITALY Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 154 ITALY Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 155 ITALY Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 156 ITALY Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 157 ITALY Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 158 ITALY Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 159 ITALY Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 160 ITALY Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 161 ITALY Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 162 ITALY Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 163 ITALY Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 164 ITALY Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 165 ITALY Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 166 ITALY Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 167 SPAIN Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 168 SPAIN Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 169 SPAIN Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 170 SPAIN Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 171 SPAIN Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 172 SPAIN Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 173 SPAIN Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 174 SPAIN Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 175 SPAIN Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 176 SPAIN Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 177 SPAIN Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 178 SPAIN Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 179 SPAIN Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 180 SPAIN Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 181 RUSSIA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 182 RUSSIA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 183 RUSSIA Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 184 RUSSIA Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 185 RUSSIA Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 186 RUSSIA Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 187 RUSSIA Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 188 RUSSIA Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 189 RUSSIA Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 190 RUSSIA Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 191 RUSSIA Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 192 RUSSIA Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 193 RUSSIA Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 194 RUSSIA Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 195 SWITZERLAND Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 196 SWITZERLAND Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 197 SWITZERLAND Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 198 SWITZERLAND Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 199 SWITZERLAND Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 200 SWITZERLAND Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 201 SWITZERLAND Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 202 SWITZERLAND Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 203 SWITZERLAND Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 204 SWITZERLAND Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 205 SWITZERLAND Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 206 SWITZERLAND Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 207 SWITZERLAND Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 208 SWITZERLAND Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 209 NETHERLANDS Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 210 NETHERLANDS Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 211 NETHERLANDS Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 212 NETHERLANDS Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 213 NETHERLANDS Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 214 NETHERLANDS Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 215 NETHERLANDS Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 216 NETHERLANDS Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 217 NETHERLANDS Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 218 NETHERLANDS Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 219 NETHERLANDS Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 220 NETHERLANDS Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 221 NETHERLANDS Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 222 NETHERLANDS Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 223 TURKEY Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 224 TURKEY Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 225 TURKEY Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 226 TURKEY Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 227 TURKEY Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 228 TURKEY Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 229 TURKEY Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 230 TURKEY Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 231 TURKEY Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 232 TURKEY Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 233 TURKEY Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 234 TURKEY Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 235 TURKEY Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 236 TURKEY Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 237 BELGIUM Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 238 BELGIUM Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 239 BELGIUM Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 240 BELGIUM Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 241 BELGIUM Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 242 BELGIUM Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 243 BELGIUM Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 244 BELGIUM Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 245 BELGIUM Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 246 BELGIUM Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 247 BELGIUM Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 248 BELGIUM Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 249 BELGIUM Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 250 BELGIUM Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 251 rest of europe Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 252 ASIA - PACIFIC PROSTATE CANCER DIAGNOSTICS MARKET, By country, 2019-2028 (USD Million)

TABLE 253 ASIA - PACIFIC Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 254 ASIA - PACIFIC Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 255 ASIA - PACIFIC Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 256 ASIA - PACIFIC Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 257 ASIA - PACIFIC Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 258 ASIA - PACIFIC Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 259 ASIA - PACIFIC Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 260 ASIA - PACIFIC Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 261 ASIA - PACIFIC Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 262 ASIA - PACIFIC Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 263 ASIA - PACIFIC Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 264 ASIA - PACIFIC Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 265 ASIA - PACIFIC Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 266 ASIA - PACIFIC Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 267 CHINA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 268 CHINA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 269 CHINA Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 270 CHINA Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 271 CHINA Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 272 CHINA Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 273 CHINA Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 274 CHINA Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 275 CHINA Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 276 CHINA Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 277 CHINA Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 278 CHINA Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 279 CHINA Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 280 CHINA Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 281 JAPAN Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 282 JAPAN Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 283 JAPAN Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 284 JAPAN Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 285 JAPAN Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 286 JAPAN Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 287 JAPAN Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 288 JAPAN Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 289 JAPAN Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 290 JAPAN Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 291 JAPAN Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 292 JAPAN Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 293 JAPAN Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 294 JAPAN Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 295 INDIA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 296 INDIA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 297 INDIA Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 298 INDIA Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 299 INDIA Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 300 INDIA Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 301 INDIA Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 302 INDIA Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 303 INDIA Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 304 INDIA Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 305 INDIA Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 306 INDIA Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 307 INDIA Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 308 INDIA Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 309 AUSTRALIA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 310 AUSTRALIA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 311 AUSTRALIA Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 312 AUSTRALIA Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 313 AUSTRALIA Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 314 AUSTRALIA Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 315 AUSTRALIA Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 316 AUSTRALIA Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 317 AUSTRALIA Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 318 AUSTRALIA Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 319 AUSTRALIA Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 320 AUSTRALIA Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 321 AUSTRALIA Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 322 AUSTRALIA Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 323 SOUTH KOREA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 324 SOUTH KOREA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 325 SOUTH KOREA Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 326 SOUTH KOREA Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 327 SOUTH KOREA Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 328 SOUTH KOREA Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 329 SOUTH KOREA Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 330 SOUTH KOREA Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 331 SOUTH KOREA Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 332 SOUTH KOREA Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 333 SOUTH KOREA Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 334 SOUTH KOREA Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 335 SOUTH KOREA Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 336 SOUTH KOREA Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 337 SINGAPORE Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 338 SINGAPORE Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 339 SINGAPORE Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 340 SINGAPORE Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 341 SINGAPORE Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 342 SINGAPORE Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 343 SINGAPORE Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 344 SINGAPORE Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 345 SINGAPORE Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 346 SINGAPORE Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 347 SINGAPORE Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 348 SINGAPORE Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 349 SINGAPORE Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 350 SINGAPORE Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 351 THAILAND Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 352 THAILAND Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 353 THAILAND Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 354 THAILAND Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 355 THAILAND Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 356 THAILAND Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 357 THAILAND Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 358 THAILAND Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 359 THAILAND Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 360 THAILAND Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 361 THAILAND Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 362 THAILAND Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 363 THAILAND Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 364 THAILAND Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 365 MALAYSIA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 366 MALAYSIA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 367 MALAYSIA Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 368 MALAYSIA Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 369 MALAYSIA Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 370 MALAYSIA Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 371 MALAYSIA Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 372 MALAYSIA Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 373 MALAYSIA Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 374 MALAYSIA Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 375 MALAYSIA Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 376 MALAYSIA Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 377 MALAYSIA Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 378 MALAYSIA Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 379 INDONESIA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 380 INDONESIA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 381 INDONESIA Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 382 INDONESIA Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 383 INDONESIA Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 384 INDONESIA Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 385 INDONESIA Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 386 INDONESIA Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 387 INDONESIA Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 388 INDONESIA Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 389 INDONESIA Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 390 INDONESIA Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 391 INDONESIA Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 392 INDONESIA Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 393 PHILIPPINES Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 394 PHILIPPINES Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 395 PHILIPPINES Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 396 PHILIPPINES Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 397 PHILIPPINES Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 398 PHILIPPINES Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 399 PHILIPPINES Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 400 PHILIPPINES Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 401 PHILIPPINES Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 402 PHILIPPINES Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 403 PHILIPPINES Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 404 PHILIPPINES Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 405 PHILIPPINES Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 406 PHILIPPINES Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 407 rest of Asia - Pacific Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 408 SOUTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET, By country, 2019-2028 (USD Million)

TABLE 409 SOUTH AMERICA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 410 SOUTH AMERICA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 411 SOUTH AMERICA Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 412 SOUTH AMERICA Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 413 SOUTH AMERICA Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 414 SOUTH AMERICA Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 415 SOUTH AMERICA Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 416 SOUTH AMERICA Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 417 SOUTH AMERICA Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 418 SOUTH AMERICA Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 419 SOUTH AMERICA Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 420 SOUTH AMERICA Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 421 SOUTH AMERICA Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 422 SOUTH AMERICA Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 423 BRAZIL Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 424 BRAZIL Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 425 BRAZIL Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 426 BRAZIL Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 427 BRAZIL Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 428 BRAZIL Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 429 BRAZIL Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 430 BRAZIL Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 431 BRAZIL Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 432 BRAZIL Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 433 BRAZIL Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 434 BRAZIL Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 435 BRAZIL Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 436 BRAZIL Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 437 ARGENTINA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 438 ARGENTINA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 439 ARGENTINA Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 440 ARGENTINA Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 441 ARGENTINA Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 442 ARGENTINA Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 443 ARGENTINA Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 444 ARGENTINA Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 445 ARGENTINA Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 446 ARGENTINA Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 447 ARGENTINA Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 448 ARGENTINA Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 449 ARGENTINA Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 450 ARGENTINA Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 451 rest of south america Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 452 MIDDLE EAST & AFRICA PROSTATE CANCER DIAGNOSTICS MARKET, By country, 2019-2028 (USD Million)

TABLE 453 MIDDLE EAST & AFRICA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 454 MIDDLE EAST & AFRICA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 455 MIDDLE EAST & AFRICA Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 456 MIDDLE EAST & AFRICA Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 457 MIDDLE EAST & AFRICA Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 458 MIDDLE EAST & AFRICA Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 459 MIDDLE EAST & AFRICA Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 460 MIDDLE EAST & AFRICA Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 461 MIDDLE EAST & AFRICA Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 462 MIDDLE EAST & AFRICA Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 463 MIDDLE EAST & AFRICA Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 464 MIDDLE EAST & AFRICA Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 465 MIDDLE EAST & AFRICA Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 466 MIDDLE EAST & AFRICA Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 467 SOUTH AFRICA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 468 SOUTH AFRICA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 469 SOUTH AFRICA Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 470 SOUTH AFRICA Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 471 SOUTH AFRICA Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 472 SOUTH AFRICA Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 473 SOUTH AFRICA Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 474 SOUTH AFRICA Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 475 SOUTH AFRICA Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 476 SOUTH AFRICA Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 477 SOUTH AFRICA Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 478 SOUTH AFRICA Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 479 SOUTH AFRICA Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 480 SOUTH AFRICA Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 481 SAUDI ARABIA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 482 SAUDI ARABIA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 483 SAUDI ARABIA Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 484 SAUDI ARABIA Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 485 SAUDI ARABIA Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 486 SAUDI ARABIA Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 487 SAUDI ARABIA Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 488 SAUDI ARABIA Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 489 SAUDI ARABIA Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 490 SAUDI ARABIA Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 491 SAUDI ARABIA Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 492 SAUDI ARABIA Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 493 SAUDI ARABIA Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 494 SAUDI ARABIA Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 495 UAE Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 496 UAE Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 497 UAE Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 498 UAE Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 499 UAE Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 500 UAE Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 501 UAE Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 502 UAE Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 503 UAE Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 504 UAE Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 505 UAE Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 506 UAE Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 507 UAE Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 508 UAE Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 509 ISRAEL Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 510 ISRAEL Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 511 ISRAEL Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 512 ISRAEL Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 513 ISRAEL Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 514 ISRAEL Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 515 ISRAEL Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 516 ISRAEL Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 517 ISRAEL Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 518 ISRAEL Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 519 ISRAEL Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 520 ISRAEL Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 521 ISRAEL Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 522 ISRAEL Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 523 EGYPT Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

TABLE 524 EGYPT Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (Units)

TABLE 525 EGYPT Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 526 EGYPT Preliminary Screening Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 527 EGYPT Confirmatory Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 528 EGYPT Imaging Tests in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 529 EGYPT Magnetic Resonance Imaging (MRI) in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 530 EGYPT Biomarker in Prostate Cancer Diagnostics Market, By Diagnostics Type, 2019-2028 (USD Million)

TABLE 531 EGYPT Prostate Cancer Diagnostics Market, By Age Group, 2019-2028 (USD Million)

TABLE 532 EGYPT Prostate Cancer Diagnostics Market, By Type, 2019-2028 (USD Million)

TABLE 533 EGYPT Prostate Cancer Diagnostics Market, By Stage, 2019-2028 (USD Million)

TABLE 534 EGYPT Prostate Cancer Diagnostics Market, By Sample Type, 2019-2028 (USD Million)

TABLE 535 EGYPT Prostate Cancer Diagnostics Market, By End Users, 2019-2028 (USD Million)

TABLE 536 EGYPT Prostate Cancer Diagnostics Market, By Distribution Channel, 2019-2028 (USD Million)

TABLE 537 rest of MIDDLE EAST & AFRICA Prostate Cancer Diagnostics Market, By Product Type, 2019-2028 (USD Million)

Liste des figures

FIGURE 1 GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: segmentation

FIGURE 2 GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET : data triangulation

FIGURE 3 GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: DROC ANALYSIS

FIGURE 4 GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: Global VS REGIONAL MARKET ANALYSIS

FIGURE 5 GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: MULTIVARIATE MODELLING

FIGURE 7 GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 8 GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: DBMR MARKET POSITION GRID

FIGURE 9 Global prostate cancer diagnostics market: MARKET end users coverage GRID

FIGURE 10 GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: VENDOR SHARE ANALYSIS

FIGURE 11 Global prostate cancer diagnostics market: SEGMENTATION

FIGURE 12 NORTH AMERICA is expected to DOMINATE and asia-pacific is growing at the fastest pace in THE global prostate cancer diagnostics market IN the forecast period of 2021 to 2028

FIGURE 13 INCREASING PREVALENCE OF PROSTATE CANCER and INCREASED RESEARCH & DEVELOPMENT IN PROSTATE CANCER DIAGNOSTICs are DRIVing THE global Prostate cancer diagnostics market IN THE FORECAST PERIOD OF 2021 to 2028

FIGURE 14 REAGENTS & CONSUMABLES segment is expected to account for the largest share of the global prostate cancer diagnostics MARKET in 2021 & 2028

FIGURE 15 asia-PACIFIC is the fastest growing market in global Prostate cancer diagnostics market in the forecast period of 2021 to 2028

FIGURE 16 REGULATORY FRAMEWORK FOR APPROVAL PROCESS IN CHINA

FIGURE 17 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET

FIGURE 18 ESTIMATED INCIDENCE CASES OF PROSTATE CANCER, ALL AGES

FIGURE 19 GERIATRIC POPULATION IN THE EUROPEAN REGION

FIGURE 20 global PROSTATE CANCER DIAGNOSTICS market: BY product type, 2020

FIGURE 21 global PROSTATE CANCER DIAGNOSTICS market: BY product type, 2020-2028 (USD Million)

FIGURE 22 global PROSTATE CANCER DIAGNOSTICS market: BY product type, CAGR (2021-2028)

FIGURE 23 PROSTATE CANCER DIAGNOSTICS market: BY product type, LIFELINE CURVE

FIGURE 24 global PROSTATE CANCER DIAGNOSTICS market: BY DIAGNOSTICS TYPE, 2020

FIGURE 25 global PROSTATE CANCER DIAGNOSTICS market: BY DIAGNOSTICS TYPE 2020-2028 (USD Million)

FIGURE 26 global PROSTATE CANCER DIAGNOSTICS market: BY DIAGNOSTICS TYPE, CAGR (2021-2028)

FIGURE 27 global PROSTATE CANCER DIAGNOSTICS market: BY DIAGNOSTICS TYPE, LIFELINE CURVE

FIGURE 28 Global prostate cancer diagnostics market: By type, 2020

FIGURE 29 Global prostate cancer diagnostics market: By type, 2020-2028 (USD Million)

FIGURE 30 Global prostate cancer diagnostics market: By type, CAGR (2020-2028)

FIGURE 31 Global prostate cancer diagnostics market: By type, LIFELINE CURVE

FIGURE 32 global PROSTATE CANCER DIAGNOSTICS market: BY age group, 2020

FIGURE 33 global PROSTATE CANCER DIAGNOSTICS market: BY age group , 2020-2028 (USD Million)

FIGURE 34 global PROSTATE CANCER DIAGNOSTICS market: BY age group, CAGR (2021-2028)

FIGURE 35 global PROSTATE CANCER DIAGNOSTICS market: BY age group, LIFELINE CURVE

FIGURE 36 global PROSTATE CANCER DIAGNOSTICS market: BY stage, 2020

FIGURE 37 global PROSTATE CANCER DIAGNOSTICS market: BY stage, 2020-2028 (USD Million)

FIGURE 38 global PROSTATE CANCER DIAGNOSTICS market: BY stage, CAGR (2021-2028)

FIGURE 39 global PROSTATE CANCER DIAGNOSTICS market: BY stage, LIFELINE CURVE

FIGURE 40 global PROSTATE CANCER DIAGNOSTICS market: BY sample type, 2020

FIGURE 41 global PROSTATE CANCER DIAGNOSTICS market: BY sample type, 2020-2028 (USD Million)

FIGURE 42 global PROSTATE CANCER DIAGNOSTICS market: BY sample type, CAGR (2021-2028)

FIGURE 43 global PROSTATE CANCER DIAGNOSTICS market: BY sample type, LIFELINE CURVE

FIGURE 44 global PROSTATE CANCER DIAGNOSTICS market: BY end users, 2020

FIGURE 45 global PROSTATE CANCER DIAGNOSTICS market: BY end users, 2020-2028 (USD Million)

FIGURE 46 global PROSTATE CANCER DIAGNOSTICS market: BY end users, CAGR (2021-2028)

FIGURE 47 global PROSTATE CANCER DIAGNOSTICS market: BY end users, LIFELINE CURVE

FIGURE 48 global PROSTATE CANCER DIAGNOSTICS market: BY distribution channel, 2020

FIGURE 49 global PROSTATE CANCER DIAGNOSTICS market: BY distribution channel, 2020-2028 (USD Million)

FIGURE 50 global PROSTATE CANCER DIAGNOSTICS market: BY distribution channel, CAGR (2021-2028)

FIGURE 51 global PROSTATE CANCER DIAGNOSTICS market: BY distribution, LIFELINE CURVE

FIGURE 52 GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: SNAPSHOT (2020)

FIGURE 53 GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: BY COUNTRY (2020)

FIGURE 54 GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: BY COUNTRY (2020 & 2028)

FIGURE 55 GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: BY COUNTRY (2020 & 2028)

FIGURE 56 GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET: BY pRODUCT type (2020-2028)

FIGURE 57 North America Prostate cancer diagnostics market: SNAPSHOT (2020)

FIGURE 58 North America Prostate Cancer Diagnostics Market: BY COUNTRY (2020)

FIGURE 59 North America PROSTATE CANCER DIAGNOSTICS MARKET: BY COUNTRY (2021 & 2028)

FIGURE 60 North America PROSTATE CANCER DIAGNOSTICS MARKET: BY COUNTRY (2020 & 2028)

FIGURE 61 North America PROSTATE CANCER DIAGNOSTICS MARKET: BY Product type (2021-2028)

FIGURE 62 EUROPE Prostate cancer diagnostics market: SNAPSHOT (2020)

FIGURE 63 EUROPE Prostate Cancer Diagnostics Market: BY COUNTRY (2020)

FIGURE 64 EUROPE PROSTATE CANCER DIAGNOSTICS MARKET: BY COUNTRY (2021 & 2028)

FIGURE 65 EUROPE PROSTATE CANCER DIAGNOSTICS MARKET: BY COUNTRY (2020 & 2028)

FIGURE 66 EUROPE PROSTATE CANCER DIAGNOSTICS MARKET: BY Product type (2021-2028)

FIGURE 67 ASIA - PACIFIC Prostate cancer diagnostics market: SNAPSHOT (2020)

FIGURE 68 ASIA - PACIFIC Prostate Cancer Diagnostics Market: BY COUNTRY (2020)

FIGURE 69 ASIA - PACIFIC PROSTATE CANCER DIAGNOSTICS MARKET: BY COUNTRY (2021 & 2028)

FIGURE 70 ASIA - PACIFIC PROSTATE CANCER DIAGNOSTICS MARKET: BY COUNTRY (2020 & 2028)

FIGURE 71 ASIA - PACIFIC PROSTATE CANCER DIAGNOSTICS MARKET: BY Product type (2021-2028)

FIGURE 72 SOUTH AMERICA Prostate cancer diagnostics market: SNAPSHOT (2020)

FIGURE 73 SOUTH AMERICA Prostate Cancer Diagnostics Market: BY COUNTRY (2020)

FIGURE 74 SOUTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: BY COUNTRY (2021 & 2028)

FIGURE 75 SOUTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: BY COUNTRY (2020 & 2028)

FIGURE 76 SOUTH AMERICA PROSTATE CANCER DIAGNOSTICS MARKET: BY Product type (2021-2028)

FIGURE 77 MIDDLE EAST & AFRICA Prostate cancer diagnostics market: SNAPSHOT (2020)

FIGURE 78 MIDDLE EAST & AFRICA Prostate Cancer Diagnostics Market: BY COUNTRY (2020)

FIGURE 79 MIDDLE EAST & AFRICA PROSTATE CANCER DIAGNOSTICS MARKET: BY COUNTRY (2021 & 2028)

FIGURE 80 MIDDLE EAST & AFRICA PROSTATE CANCER DIAGNOSTICS MARKET: BY COUNTRY (2020 & 2028)

FIGURE 81 MIDDLE EAST & AFRICA PROSTATE CANCER DIAGNOSTICS MARKET: BY Product type (2021-2028)

FIGURE 82 Global Prostate cancer diagnostics market: company share 2020 (%)

FIGURE 83 north america Prostate cancer diagnostics market: company share 2020 (%)

FIGURE 84 europe Prostate cancer diagnostics market: company share 2020 (%)

FIGURE 85 Asia-Pacific Prostate cancer diagnostics market: company share 2020 (%)

Voir les informations détaillées Right Arrow

Méthodologie de recherche

La collecte de données et l'analyse de l'année de base sont effectuées à l'aide de modules de collecte de données avec des échantillons de grande taille. L'étape consiste à obtenir des informations sur le marché ou des données connexes via diverses sources et stratégies. Elle comprend l'examen et la planification à l'avance de toutes les données acquises dans le passé. Elle englobe également l'examen des incohérences d'informations observées dans différentes sources d'informations. Les données de marché sont analysées et estimées à l'aide de modèles statistiques et cohérents de marché. De plus, l'analyse des parts de marché et l'analyse des tendances clés sont les principaux facteurs de succès du rapport de marché. Pour en savoir plus, veuillez demander un appel d'analyste ou déposer votre demande.

La méthodologie de recherche clé utilisée par l'équipe de recherche DBMR est la triangulation des données qui implique l'exploration de données, l'analyse de l'impact des variables de données sur le marché et la validation primaire (expert du secteur). Les modèles de données incluent la grille de positionnement des fournisseurs, l'analyse de la chronologie du marché, l'aperçu et le guide du marché, la grille de positionnement des entreprises, l'analyse des brevets, l'analyse des prix, l'analyse des parts de marché des entreprises, les normes de mesure, l'analyse globale par rapport à l'analyse régionale et des parts des fournisseurs. Pour en savoir plus sur la méthodologie de recherche, envoyez une demande pour parler à nos experts du secteur.

Personnalisation disponible

Data Bridge Market Research est un leader de la recherche formative avancée. Nous sommes fiers de fournir à nos clients existants et nouveaux des données et des analyses qui correspondent à leurs objectifs. Le rapport peut être personnalisé pour inclure une analyse des tendances des prix des marques cibles, une compréhension du marché pour d'autres pays (demandez la liste des pays), des données sur les résultats des essais cliniques, une revue de la littérature, une analyse du marché des produits remis à neuf et de la base de produits. L'analyse du marché des concurrents cibles peut être analysée à partir d'une analyse basée sur la technologie jusqu'à des stratégies de portefeuille de marché. Nous pouvons ajouter autant de concurrents que vous le souhaitez, dans le format et le style de données que vous recherchez. Notre équipe d'analystes peut également vous fournir des données sous forme de fichiers Excel bruts, de tableaux croisés dynamiques (Fact book) ou peut vous aider à créer des présentations à partir des ensembles de données disponibles dans le rapport.

Questions fréquemment posées

The prostate cancer diagnostics market size will be worth USD 9.327.01 million by 2031.
The growth rate of the prostate cancer diagnostics market is 10.50% during the forecast period by 2031.
The increasing aging population & rising incidence of prostate cancer are the growth drivers of the prostate cancer diagnostics market.
Product type, diagnostics type, age group, type, stage, sample type, end-user, and distribution channel are the factors on which the prostate cancer diagnostics market research is based.
Major companies in the prostate cancer diagnostics market are F. Hoffmann-La Roche Ltd (Switzerland), ACON Laboratories, Inc. (U.S.), HUMASIS (South Korea), Teco Diagnostics (U.S.), Hologic Inc. (U.S.), Accuquik Test Kits (U.S.), MDxHealthcare (Belgium), Abbott (U.S.), Siemens Healthcare GmbH (Germany), OPKO Health Inc. (U.S.), Myriad Genetics, Inc. (U.S.), DiaSorin S.p.A (Italy), Beckman Coulter, Inc. (a subsidiary of Danaher) (U.S.), Genomic Health, Inc. (a subsidiary of Exact Sciences Corporation) (U.S.), bioMérieux SA (France), Metamark Genetics, Inc. (U.S.), Prostatype Genomics (Switzerland), Fujirebio (Belgium), Proteomedix (Switzerland), Eurolyser Diagnostica GmbH (Austria).

Parcourir les pages associées

Banner